APA (7th ed.) Citation

Asal Neshatbini Tehrani, Behzad Hatami, Ghazal Daftari, Azita Hekmatdoost, Zahra Yari, Amin Salehpour, . . . Bizhan Helli. (2024). The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: A randomized placebo controlled clinical trial. BMC.

Chicago Style (17th ed.) Citation

Asal Neshatbini Tehrani, Behzad Hatami, Ghazal Daftari, Azita Hekmatdoost, Zahra Yari, Amin Salehpour, Seyed Ahmad Hosseini, and Bizhan Helli. The Effect of Soy Isoflavones Supplementation on Metabolic Status in Patients with Non-alcoholic Fatty Liver Disease: A Randomized Placebo Controlled Clinical Trial. BMC, 2024.

MLA (9th ed.) Citation

Asal Neshatbini Tehrani, et al. The Effect of Soy Isoflavones Supplementation on Metabolic Status in Patients with Non-alcoholic Fatty Liver Disease: A Randomized Placebo Controlled Clinical Trial. BMC, 2024.